Physician profile
Akbar Umar
NPI 1336122662
$589.86
in general payments reported to CMS, 2019-2025
10 companies · $135 in 2025
The $135 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.57 · 2020: $25.50 · 2023: $118 · 2024: $269 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $267.79 | 2019-2025 | Bexsero, Trelegy Ellipta, Arexvy |
| Exact Sciences Corporation | $94.29 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $86.15 | 2023-2024 | Dificid |
| Sobi, INC | $25.50 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $23.70 | 2023 | Opsumit, Uptravi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.89 | 2023 | Xifaxan |
| Dynavax Technologies Corporation | $21.99 | 2023 | Heplisav-B |
| Lilly USA, LLC | $19.68 | 2023 | Mounjaro |
| Novo Nordisk INC | $14.07 | 2019 | |
| Silk Road Medical, INC. | $13.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akbar Umar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.